MedPath

The Impact of Omega-3 on Dry Eye

Not Applicable
Conditions
Dry eye.
other disorders of lacrimal gland
Registration Number
IRCT201012265467N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

Inclusion Criteria: Subjects with Tear Break up time of less than 10 seconds

Exclusion Criteria

The subjects with blood coagulation problems and those who take blood thinning medications such as warfarin or Coumadin, subject with the history of stomach ulcer, hemorrhage, or surgery in the past three months, history of allergies to fish oil or gelatinous capsules.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tear Break Up time. Timepoint: Before and after one month intervention. Method of measurement: The time that takes for the first dry spot to appear following blinking after fluorescin instillation.;Tear secretion. Timepoint: Before and after intervention. Method of measurement: Schirmer test- Wetting of the filter paper after 5 minutes.;Foreign body sensation, photophobia, blur vision, Burning. Timepoint: Before and after intervention. Method of measurement: Filling OSDI questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath